Darintr Sosothikul

19PUBLICATIONS
51CO-AUTHORS
HaematologyHumoural immunology and immunochemistryTumour immunologyBiomechanicsStudies of Asian society
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 14, 2026
HEAD-US Score and Cartilage Biomarkers in Patients With Severe Haemophilia A Who Receive Low-Dose Factor VIII Prophylaxis.

Arpanan Pramualratthakarn, Chatphatai Moonla, Numphung Numkarunarunrote

|Dec 31, 2024
Low-Dose Emicizumab Versus Low-/Intermediate-Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype.

Nuchanun Kessakorn, Itsaraet Gosriwatana, Nuttarak Sasipong

|Oct 05, 2024
Evaluating the benefits of emicizumab prophylaxis for haemophilia A with inhibitors: A cost-effectiveness and budget impact analysis in Thailand's upper-middle income setting.

Kirati Kengkla, Preyanate Wilairat, Rungrote Natesirinilkul

|Jul 09, 2024
F8 variants and their genotype-phenotype correlations in Thai patients with haemophilia A: a nationwide multicentre study.

Chayanit Trirut, Darintr Sosothikul, Rungnapa Ittiwut

|Mar 27, 2024
Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis.

Chonlatis Srichumpuang, Arunothai Rakmanotham, Chatphatai Moonla

Pageof 4